Valproate-associated weight gain and potential predictors in children with epilepsy |
Jang, Gook Chan
(Department of Pediatrics, College of Medicine, Chosun University)
Kim, Eun Young (Department of Pediatrics, College of Medicine, Chosun University) Rho, Young Il (Department of Pediatrics, College of Medicine, Chosun University) Moon, Kyung Rye (Department of Pediatrics, College of Medicine, Chosun University) Park, Sang Kee (Department of Pediatrics, College of Medicine, Chosun University) |
1 | Maffei M, Halaas J, Ravussin E. Leptin level is human and Rodent: measurement of plasma leptin and ob gene RNA in obese and weight-reduced subjects. Nat Med 1995;1:1155- 61 DOI |
2 | Dornhorst A, Jenkins JS. The evaluation of sodium valproate treatment of Nelson's syndrome. J Clin Endocrinol Metab 1983;56:985-91 DOI |
3 | Corman CL, Leung NM, Guberman AH. Weight gain in epileptic patients during treatment with valproic acid: A retrospective study. Can J Neurol Sci 1997;24:240-4 DOI |
4 | Biton V, Mirza W, Montouris G, Vuong A, Hammer AE, Barrett PS. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurology 2001;56:172-7 DOI ScienceOn |
5 | Demir E, Aysun S. Weight gain associated with valproate in children. Pediatr Neurol 2000;22:361-4 DOI ScienceOn |
6 | Wirrell EC, Camfield CS, Camfield PR, Dooley JM, Gordon KE, Smith B. Long-term psychosocial outcome in typical absence epilepsy: Sometimes a wolf in sheeps' clothing. Arch Pediatr Adolesc Med 1997;151:152-8 DOI ScienceOn |
7 | Austin JK, Smith MS, Risinger MW, McNelis AM. Childhood epilepsy and asthma: Comparison of quality of life. Epilepsia 1994;35:608-15 DOI ScienceOn |
8 | Wirrell EC. Valproic acid-associated weight gain in older children and teens with epilepsy. Pediatr Neurol 2003;28: 126-9 DOI ScienceOn |
9 | Verrotti A, Basciani F, Moresi S, de Martino M, Morgese G, Hiarelli F. Serum leptin changes in epileptic patients who gain weight after therapy with valproic acid. Neurology 1999;53:230-2 DOI |
10 | Isojarvi JI, Rattya J, Myllyla VV, Knip M, Koivunen R, Pakarinen AJ, Tekay A, Tapanainen JS. Valproate, lamotrigen, and insulin-mediated risks in women with epilepsy. Ann Neurol 1998;43:446-51 DOI ScienceOn |
11 | Kim IC, Kim ES, Bae EJ, Park WI, Lee HG, Lee KJ. The pattern of weight gain and change of peripheral serum lipid profiles in idiopathic epileptic children treated with valproate. J Korean Child Neurol Soc 2002;10:81-6 |
12 | Yoon WS, Ryu NE, Woo YJ. Serum leptin levels in epileptic children with anticonvulsant medication. J Korean Child Neurol Soc 1999;6:285-9 |
13 | Turnbull DM, Dick DJ, Wilson L, Sherratt HS, Alberti KG. Valproate causes metabolic disturbance in normal man. J Neurol Neurosurg Psychiatry 1986;49:405-10 DOI |
14 | Egger J, Brett EM. Effects of sodium valproate in 100 children with special reference to weight. BMJ 1981; 283:577-81 DOI |
15 | Breum L, Astrup A, Gram L. Metabolic changes during treatment with valproate in humans: Implication for untoward weight gain. Metabolism 1992;41:S29-37 |
16 | Astrup AV. Sodium valproate promotes obesity by reducing energy expenditure. Int J Obesity 1983;13:126 |
17 | Panksepp J, Meeker RB. The role of GABA in the ventro medical hypothalamic regulation of food intake. Brain Res Bull 1980;5:453-60 DOI ScienceOn |
18 | Kim SJ, Park HS, Hwang JS, Jung YJ, Ko TS. Change of body weight according to antiepileptic drugs in children with epilepsy: Valproic Acid vs. Topiramate. J Korean Child Neurol Soc 2003;11;68-72 |
19 | Rogers V, Vandenberghe Y, Vercruysse A. Inhibition of gluconeogenesis by so dium valproate and its metabolites in rat hepatocytes. Xenobiotica 1985;15:759-65 DOI ScienceOn |
20 | Shoenfeld WN, Warden CH. Pediatric obesity. An overview of etiology and treatment. Pediatric Clin North Am 1997;44; 339-61 DOI |
21 | Isojarvi JIT, Laatikainen TJ, Knip M, Pakarinen AJ, Juntunen KTS, Myllyla VV. Obesity and endocrine disorders in women taking valproate for epilepsy. Ann Neurol 1996; 39:579-84 DOI ScienceOn |
22 | Vorum H, Gram L, Honore B. Valproate and palmitate binding to serum albumin in valproate-treated patients: Relation to obesity. Epilepsy Res 1993;16:55-64 DOI ScienceOn |
23 | Dinesen H, Gram L, Andersen T, Dam M. Weight gain during treatment with valproate. Acta Neurol Scand 1984; 70:65-9 |
24 | Considine RV, Sinha MK, Heiman ML. Serum immunoreactive leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;34:292-5 |